(3R,4S) -Tofacitinib

(3R,4S) -Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.

Product Specifications

CAS Number

[1092578-46-5]

UNSPSC

12352005

Hazard Statement

H302-H360

Target

JAK

Type

Reference compound

Related Pathways

Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/_3R,4S_-Tofacitinib.html

Purity

99.88

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

CN(C1=NC=NC2=C1C=CN2)[C@@H]3[C@@H](C)CCN(C(CC#N)=O)C3

Molecular Formula

C16H20N6O

Molecular Weight

312.37

Precautions

P264-P270-P280-P330-P405-P501

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

TA808560 100 µL

EPLIN (LIMA1) Mouse Monoclonal Antibody [Clone ID: OTI9F3]

View Details

RR202454L3 10 µg

Ggct (NM_001108629) Rat Tagged Lenti ORF Clone

View Details

sc-33686 AF647 200 µg/mL

NCAM-L1 (5G3) Alexa Fluor® 647

View Details

342463-01 100 µL

CEP55 discontinued

View Details

342463-02 200 µL

CEP55 discontinued

View Details

220253 10 µg

SDF-1a, Recombinant, Rat (CXCL2, Stromal-Cell Derived Factor-1, CXCL12, PBSF, SDF-1) discontinued

View Details